menu
    • menu

    Company profile for Affibody

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Affibody is a private clinical-stage Swedish biotech company focused on developing into an integrated biopharma company utilizing next generation biotherapeutics based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. The company operates a focused experimental medicine model and currently has three clinical stage programs. The first two are therapeutic programs that targets psoriasis, and...
    Affibody is a private clinical-stage Swedish biotech company focused on developing into an integrated biopharma company utilizing next generation biotherapeutics based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. The company operates a focused experimental medicine model and currently has three clinical stage programs. The first two are therapeutic programs that targets psoriasis, and B-cell driven autoimmune diseases respectively. The third program is a diagnostic imaging program that is directed primarily towards metastatic breast cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AffibodySweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Scheeles väg 2, SE-171 65 Solna
    Telephone
    Telephone
    +46 (0)8 59 88 38 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.affibody.se/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chiesi, Affibody sign $637M respiratory disease collab
    Chiesi, Affibody sign $637M respiratory disease collab

    08 Mar 2023

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chiesi-offers-affibody-breath-fresh-air-new-respiratory-disease-deal-worth-637m-biobucks

    FIERCE BIOTECH
    08 Mar 2023
    Share Share
    ACELYRIN, Affibody. Inmagene Biopharma Announce Data from PII Trial of Izokibep
    ACELYRIN, Affibody. Inmagene Biopharma Announce Data from PII Trial of Izokibep

    03 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/acelyrin-inc-affibody-ab-and-inmagene-biopharmaceuticals-announce-data-from-global-phase-2-trial-of-izokibep-in-patients-with-psoriatic-arthritis-presented-during-2022-european-alliance-of-associations-for-rheumatology-congress-301560613.html

    PRNEWSWIRE
    03 Jun 2022
    Share Share
    ACELYRIN, Affibody & Inmagene Shows +ve Interim Results from Phase 2 of Izokibep
    ACELYRIN, Affibody & Inmagene Shows +ve Interim Results from Phase 2 of Izokibep

    13 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/acelyrin-inc-affibody-ab-and-inmagene-biopharmaceuticals-announce-positive-interim-results-from-global-phase-2-trial-of-izokibep-in-patients-with-psoriatic-arthritis-301443555.html

    PRNEWSWIRE
    13 Dec 2021
    Share Share
    Acelyrin snags $250M, licenses Affibody IL-17 asset for 3 trials
    Acelyrin snags $250M, licenses Affibody IL-17 asset for 3 trials

    16 Nov 2021

    // Kyle LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/acelyrin-reels-250m-to-fund-three-late-stage-trials-inflammatory-disease-antibody-licensed

    Kyle LaHucik FIERCEBIOTECH
    16 Nov 2021
    Share Share
    Affibody and Inmagene announce First Patient Dosed in Phase 2 ASPIRE Trial
    Affibody and Inmagene announce First Patient Dosed in Phase 2 ASPIRE Trial

    25 Aug 2021

    // PRESS RELEASE

    https://www.mynewsdesk.com/se/affibody/pressreleases/affibody-and-inmagene-announce-first-patient-dosed-in-the-global-phase-2-aspire-trial-of-izokibep-for-patients-with-active-ankylosing-spondylitis-3123231

    PRESS RELEASE
    25 Aug 2021
    Share Share
    Affibody Announces Initiation of Confirmatory Phase 2 Trial of ABY-035
    Affibody Announces Initiation of Confirmatory Phase 2 Trial of ABY-035

    10 Nov 2020

    // MYNEWSDESK

    https://www.mynewsdesk.com/se/affibody/pressreleases/affibody-announces-initiation-of-confirmatory-phase-2-trial-of-aby-035-in-psoriatic-arthritis-patients-3049819

    MYNEWSDESK
    10 Nov 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search